5:19 PM ET
8-K
Capital Raise
Traws Pharma Capital Raise
Traws Pharma entered into a common stock purchase agreement with Roth Principal Investments for an equity line of credit of up to $50 million. The company has the right, but not the obligation, to sell shares to Roth over a 36-month period following the effectiveness of a registration statement. This facility provides the company with flexible access to capital to fund operations at its sole discretion.
- Counterparty
- Roth Principal Investments, LLC
- Term
- 36 months